Orbion
Orbion helps pharmaceutical and biotech companies accelerate their drug discovery process with its proprietary AI models.
Antler
antler-portfolio #1428Orbion helps pharmaceutical and biotech companies accelerate their drug discovery process with its proprietary AI models.
sourceOrbion is classified as AI infrastructure from source descriptions and fund-directory context. Similar companies below are ranked from offline product facets and meaningful description overlap; category and source affiliation can only strengthen an existing product match. For lookup-created rows, the profile starts as pending enrichment until deeper source collection runs.
Local clusters rerank extracted product concepts and description terms. The generated graph remains the fallback for sparse descriptions: offline reciprocal product-similarity graph: extracted concepts + description terms + bounded category/affiliation boosts. Minimum fallback score: 0; max competitors: 6.
Companies similar to Orbion
A deterministic local cluster built from offline product facets and meaningful description terms. Category and selected-institution affiliation provide bounded tie-breaks. Open any peer to continue exploring its cluster.
Strand AI
match 65Strand AI develops foundation models to generate missing bio-data about patients. With this imputed data, pharmaceutical companies can select better patients for their drug trials and shave months from their drug launch timelines. We’ve already trained a multimodal foundation model that integrates spatial biology modalities, beating SOTA at a fraction of the cost.
shared extracted concept terms: pharmaceutical, companie, model; shared product terms: pharmaceutical, companie, drug, model; same category: AI infrastructure
G LNK
match 65G LNK is an AI-powered platform simplifying how healthcare companies connect with the relevant medical professionals. Our proprietary matching and ranking models instantly identify the most qualified experts, accelerating drug development and commercialization. Designed with compliance at its core, G LNK ensures every connection meets strict regulatory and ethical standards—empowering companies to innovate faster with confidence.
shared extracted concept terms: companie, proprietary, model; shared product terms: companie, proprietary, model, drug; same category: AI infrastructure
Sway Finance
match 57Sway is bringing artificial intelligence to the accounting industry. Its first product is an automated bookkeeping service for SaaS companies. We use a combination of proprietary machine learning models and API integrations to bring our delightfully low-touch experience to the accounting industry. Learn more: hello@swayfinance.com
shared extracted concept terms: companie, proprietary, model; shared product terms: companie, proprietary, model; same category: AI infrastructure
Transcriptic
match 54Founded in 2012, Transcriptic has developed the first robotic cloud lab platform for on-demand life science research. It’s powered by the Transcriptic Common Lab Environment (TCLE) a scalable, digital infrastructure that integrates laboratory processes, instruments and IoT technologies into a single user interface. Researchers can carry out scalable, reproducible and rapid experimentation from anywhere in the world. Top ten pharmaceutical companies, as well as emerging biotech companies, are usi
shared extracted concept terms: pharmaceutical, biotech, companie; shared product terms: pharmaceutical, biotech, companie
Andson Biotech
match 52Andson Biotech helps pharmaceutical companies measure difficult to detect chemicals that they need to measure while developing and manufacturing drugs like cell-therapies or biologics. Drug companies want to use our technologies to get fast and accurate chemical measurements they do thousands of times per day for drug development and quality control.
shared extracted concept terms: pharmaceutical, companie; shared product terms: biotech, pharmaceutical, companie, drug
Macromoltek
match 44Macromoltek: Revolutionizing antibody design. Description: Macromoltek, a computational de novo drug design company, rapidly produces accurate and credible antibody designs. We have built a proprietary platform that enables design against difficult targets inaccessible by traditional methods and have are already designing antibodies for large biopharmas and smaller biotechs.
shared extracted concept terms: biotech, proprietary; shared product terms: drug, proprietary, biotech